Status:
TERMINATED
Effect of Chronic Supplementation of L-arginine in the Muscular Performance
Lead Sponsor:
Sanofi
Conditions:
Muscular Fatigue
Eligibility:
All Genders
20-55 years
Phase:
PHASE4
Brief Summary
The primary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular fatigue of the quadriceps, expressed in terms of the Fatigue Resistance Factor (FRF). T...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Healthy young adults for both sex; Age between 20 and 55 years; Slight or moderate physical activity, 30 minutes per day, at least 3 times a week;
- Exclusion criteria:
- Cardiac or pulmonary disease; Previous history of knee surgery or skeletal muscular dysfunctions in hip, knee or ankle joints; Athletic person (intensive anaerobic activity); None practiced of physical activity regularly; Medications usage
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Exclusion
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00785811
Start Date
October 1 2008
End Date
December 1 2008
Last Update
March 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis Administrative Office
São Paulo, Brazil